Recombination is a fundamental property of genetic material, which allows patterns of evolutionary change that would be virtually impossible without it. Although normally associated with sexual reproduction, recombination may also play a critical role in allowing non-sexually reproducing organisms to adapt to a changing environment. In the case of HIV-1, the recombigenic potential of this retrovirus has been noted in settings in which individuals were dually infected with two divergent viral variants. However, the high mutation rate of this virus, along with its rapid replication to high level and long persistence within the infected host, permit enough diversity to develop to allow the detection, by recently developed techniques, of recombination events within individuals infected with monophyletic viruses. The potential impact of such recombination on disease course, especially in the face of multi-drug therapy which can only be resisted through the acquisition of numerous mutations, is the focus of the proposed studies.
The specific aims are to 1) Sequence regions of the env and pol gene from 24 individuals infected by a single source of HIV-1 and followed longitudinally in order to monitor intrahost evolution. 2) Simultaneously estimate the evolutionary trees and recombinational history from the sequence data using newly developed analytical procedures. 3) Use the longitudinal data available on each individual to examine the evolutionary fate of recombinant versus non-recombinant haplotypes in order to test for interactions between recombination, selection, and adaptive evolution of HIV-1. The analysis will separate the effects of intragenic versus intergenic recombination. 4) Test for associations between the evolutionary patterns observed for recombinants and the course of disease progression and treatment regimes. These studies should provide critical insights into the potential rate of emergence of multi-drug resistant variants of HIV-1.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
1R01GM060730-01
Application #
6052766
Study Section
Special Emphasis Panel (ZRG1-GEN (01))
Project Start
1999-09-30
Project End
2003-08-31
Budget Start
1999-09-30
Budget End
2000-08-31
Support Year
1
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Johns Hopkins University
Department
Microbiology/Immun/Virology
Type
Schools of Public Health
DUNS #
045911138
City
Baltimore
State
MD
Country
United States
Zip Code
21218
Kowalski, Jeanne; Gange, Stephen J; Schneider, Michael F et al. (2009) Relationship of injection drug use, antiretroviral therapy resistance, and genetic diversity in the HIV-1 pol gene. J Acquir Immune Defic Syndr 50:381-9
Templeton, Alan R; Kramer, Melissa G; Jarvis, Joseph et al. (2009) Multiple-infection and recombination in HIV-1 within a longitudinal cohort of women. Retrovirology 6:54
Templeton, Alan R; Reichert, Rebecca A; Weisstein, Anton E et al. (2004) Selection in context: patterns of natural selection in the glycoprotein 120 region of human immunodeficiency virus 1 within infected individuals. Genetics 167:1547-61